If you need more lookups,
subscriptions start at $34 USD/month.
Craig Chatham Location
Wellesley, MA, US
Craig Chatham Work
Head of Financial Planning and Analysis and Financial Systems @ (August 2021 - Present)
Finance Director, Head of Financial Planning and Analysis @ Sumitomo Dainippon Pharma Oncology (formerly Boston Biomedical, Inc.) (May 2019 - August 2021)
Shire @
Director Finance, Global Technical Operations @ Shire (formerly NPS Pharma) (January 2014 - May 2015)
Associate Director, Global Strategic Account Finance @ (January 2012 - January 2013)
Manager, Financial Planning and Analysis @ (January 2008 - January 2012)
Senior Financial Auditor @ (January 2000 - January 2008)
Senior Research Associate, Analytical Chemistry @ (January 1995 - January 1998)
Craig Chatham Education
University of Rochester
Master Of Business Administration (Accounting, Finance)
1998-2000
Lehigh University
Bachelor Of Arts (Biology)
1991-1995
Craig Chatham Skills
Accounting
Analysis
Biotechnology
Cross-functional Team Leadership
FRx Reporting
Finance
Financial Analysis
Financial Modeling
Financial Reporting
Great Plains Software
Lotus Notes
LotusNotes
Management
Microsoft Dynamics GP
Microsoft Excel
Microsoft Powerpoint
Microsoft Word
Pharmaceutical Industry
PowerPoint
Process Improvement
SAP
Sarbanes-Oxley Act
Strategic Financial Planning
MD&A
Financial Advisory
Clinical Trials
Sound
Suppliers
Insurance
Expenses
Demand Planning
Cost Accounting
Phase Ii
Concentrations
Cost
Accruals
Infectious Diseases
Clinical Research
Supply Chain Management
Cycles
Market Information
Information System
Proxy
Driving
Change Orders
Business Administration
Savings
Business Partners
Cross Functional Team Leadership
Scholarships
Int
Assessment
Disclosures
Advantages
Revenue
Financial Statements
Insurance Planning
Phase 1
Technical Operations
Long Range
Metrics
Allocations
Strategic Account
Steering
Initiation
Committees
New Initiatives
Auditing
Monitors
Circulation
Quarter
Approvals
Pennsylvania
Financial Forecasting
Profit
Valuation
Scorecard
System
Charges
Cogs
Utilization
Reports
Direct Materials
Strategy
Inventory
Equity Research
Budgeting
Testing
New Business Development
Piloting
FRx
Training
Drug Development
Monthly Closings
Patient
Contract Negotiation
Supply
Documentation
Mitigation
Research
Reporting
Close Process
OPs
Capital
Raritan
Manufacturing Processes
Business Control
Board of Directors
Springs
Comparisons
Jersey
Corporate Finance
Journal Entries
Controllers
Financial Tracking
Schedules
Phase 2
IV
ERP
Operations
Summaries
Standard Costs
Analytical Chemistry
Business Partner
Revenue Recognition
Business Case
Pipelines
Project Planning
Project
Sarbanes Oxley Act
Golang
Contractual Agreements
Metric
CMO
Thinking
Pricing
Internal Audit
Project Teams
Policies and Procedures
Labor Issues
International
Art
CRO
Biology
Google Groups
Executive Management
Portfolio
Intercompany
Headcount
Target Costing
Tax
Sourcing
New York
Reviews
Concerts
Net Promoter Score
Psychology
Ross
Pharmaceutics
Internal Controls
Financial Planning and Analysis
Summary Reports
External Manufacturing
Market Analysis
Invoicing
Budgets
Risk
Conceptual Modeling
Meetings
Evaluation
Americas
Coordinated
Coordinate
Financial Results
Craig Chatham Summary
Craig Chatham, based in Wellesley, MA, US, is currently a Head of Financial Planning and Analysis and Financial Systems at EyePoint Pharmaceuticals. Craig Chatham brings experience from previous roles at Sumitomo Dainippon Pharma Oncology (formerly Boston Biomedical, Inc.), Shire, Shire (formerly NPS Pharma) and Covance. Craig Chatham holds a 1998 - 2000 Master Of Business Administration in Accounting, Finance @ University of Rochester. With a robust skill set that includes Accounting, Analysis, Biotechnology, Cross-functional Team Leadership, FRx Reporting and more. Craig Chatham has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Craig Chatham?
Find contact details for 700 million professionals.